Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-26

Clinical Trial Update: Sancuso® for Gastroparesis: An Open Label Study. [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial update for Sancuso in gastroparesis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SANCUSO (GRANISETRON)

Snippet

Sponsor: Temple University | Conditions: Gastroparesis | Phase 3 | Status: COMPLETED | Results posted: 2021-05-26